chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: cannot eat anything; Can not go to work; diarrhea; Rash on the arm at the injection site; fatigue; muscle pain; chills; Rash is swollen on the arm at the injection site; Rash is red on the arm at the injection site; Rash is itchy on the arm at the injection site; Rash is painful on the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site) and VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site), VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site), VACCINATION SITE PRURITUS (Rash is itchy on the arm at the injection site), VACCINATION SITE PAIN (Rash is painful on the arm at the injection site) and VACCINATION SITE RASH (Rash on the arm at the injection site). On 17-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and IMPAIRED WORK ABILITY (Can not go to work). On an unknown date, the patient experienced DECREASED APPETITE (cannot eat anything). At the time of the report, FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site), VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site), VACCINATION SITE PRURITUS (Rash is itchy on the arm at the injection site), VACCINATION SITE PAIN (Rash is painful on the arm at the injection site), DIARRHOEA (diarrhea), DECREASED APPETITE (cannot eat anything), IMPAIRED WORK ABILITY (Can not go to work) and VACCINATION SITE RASH (Rash on the arm at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product usage were not provided. Treatment details were not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: cannot eat anything; Can not go to work; diarrhea; Rash on the arm at the injection site; fatigue; muscle pain; chills; Rash is swollen on the arm at the injection site; Rash is red on the arm at the injection site; Rash is itchy on the arm at the injection site; Rash is painful on the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site) and VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site), VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site), VACCINATION SITE PRURITUS (Rash is itchy on the arm at the injection site), VACCINATION SITE PAIN (Rash is painful on the arm at the injection site) and VACCINATION SITE RASH (Rash on the arm at the injection site). On 17-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and IMPAIRED WORK ABILITY (Can not go to work). On an unknown date, the patient experienced DECREASED APPETITE (cannot eat anything). At the time of the report, FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), VACCINATION SITE SWELLING (Rash is swollen on the arm at the injection site), VACCINATION SITE ERYTHEMA (Rash is red on the arm at the injection site), VACCINATION SITE PRURITUS (Rash is itchy on the arm at the injection site), VACCINATION SITE PAIN (Rash is painful on the arm at the injection site), DIARRHOEA (diarrhea), DECREASED APPETITE (cannot eat anything), IMPAIRED WORK ABILITY (Can not go to work) and VACCINATION SITE RASH (Rash on the arm at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product usage were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itching on the skin of both her arms and hands which comes and goes; ittle bit of a rash" on her arms and hands; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on the skin of both her arms and hands which comes and goes) and RASH (ittle bit of a rash" on her arms and hands) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRURITUS (itching on the skin of both her arms and hands which comes and goes) and RASH (ittle bit of a rash" on her arms and hands). At the time of the report, PRURITUS (itching on the skin of both her arms and hands which comes and goes) and RASH (ittle bit of a rash" on her arms and hands) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient said she was scheduled for 2nd dose on 21Apr2021. The concomitant medications information was not reported. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 antibody test positive
Clinical narrative: Diagnosed with Covid after first shot; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST POSITIVE (Diagnosed with Covid after first shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST POSITIVE (Diagnosed with Covid after first shot). At the time of the report, SARS-COV-2 ANTIBODY TEST POSITIVE (Diagnosed with Covid after first shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, SARS-CoV-2 antibody test: negative (Negative) Negative. On an unknown date, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient said she was scheduled for second dose on 03May2021.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itchiness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and PRURITUS (Itchiness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Patient mentioned taking medication for Blood sugar, Blood Pressure and cholesterol). Concomitant products included LOSARTAN for Blood pressure, ROSUVASTATIN for Cholesterol, GLIPIZIDE and METFORMIN for Diabetic.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced RASH (Rash) and PRURITUS (Itchiness). At the time of the report, RASH (Rash) and PRURITUS (Itchiness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment: Patient was using calamine lotion for the Symptoms
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dyspnoea, Fatigue, Headache
Clinical narrative: occasionally shortness of breathe; lost smell and taste; lost smell and taste; "flu like aches"; fatigue; nausea; fever 102 degrees Fahrenheit; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (occasionally shortness of breathe), ANOSMIA (lost smell and taste), AGEUSIA (lost smell and taste), MYALGIA ("flu like aches") and FATIGUE (fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in August 2020. Concomitant products included ALPRAZOLAM, ACETYLSALICYLIC ACID (ASPIRIN 81), CLONAZEPAM, CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), CETIRIZINE, CLONIDINE, CYCLOBENZAPRINE, FLUOXETINE, FLUTICASONE, GABAPENTIN, INSULIN LISPRO (HUMALOG), SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), EMPAGLIFLOZIN (JARDIANCE), LANSOPRAZOLE, LISINOPRIL and MELOXICAM for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (occasionally shortness of breathe), ANOSMIA (lost smell and taste), AGEUSIA (lost smell and taste), MYALGIA ("flu like aches"), FATIGUE (fatigue), NAUSEA (nausea), PYREXIA (fever 102 degrees Fahrenheit) and HEADACHE (bad headache). On 24-Mar-2021, DYSPNOEA (occasionally shortness of breathe), ANOSMIA (lost smell and taste), AGEUSIA (lost smell and taste), MYALGIA ("flu like aches"), FATIGUE (fatigue), NAUSEA (nausea), PYREXIA (fever 102 degrees Fahrenheit) and HEADACHE (bad headache) had resolved.      No treatment of symptoms for Dose 1 was provided. Additional concomitant medication was Vitamin D 50000 twice a week.   This case was linked to US-MODERNATX, INC.-MOD-2021-081412 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081412:Case for dose 2
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: occasionally shortness of breathe; lost smell and taste; lost smell and taste; "flu like aches"; fatigue; nausea; fever 102 degrees Fahrenheit; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (occasionally shortness of breathe), ANOSMIA (lost smell and taste), AGEUSIA (lost smell and taste), MYALGIA ("flu like aches") and FATIGUE (fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in August 2020. Concomitant products included ALPRAZOLAM, ACETYLSALICYLIC ACID (ASPIRIN 81), CLONAZEPAM, CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), CETIRIZINE, CLONIDINE, CYCLOBENZAPRINE, FLUOXETINE, FLUTICASONE, GABAPENTIN, INSULIN LISPRO (HUMALOG), SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), EMPAGLIFLOZIN (JARDIANCE), LANSOPRAZOLE, LISINOPRIL and MELOXICAM for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (occasionally shortness of breathe), ANOSMIA (lost smell and taste), AGEUSIA (lost smell and taste), MYALGIA ("flu like aches"), FATIGUE (fatigue), NAUSEA (nausea), PYREXIA (fever 102 degrees Fahrenheit) and HEADACHE (bad headache). On 24-Mar-2021, DYSPNOEA (occasionally shortness of breathe), ANOSMIA (lost smell and taste), AGEUSIA (lost smell and taste), MYALGIA ("flu like aches"), FATIGUE (fatigue), NAUSEA (nausea), PYREXIA (fever 102 degrees Fahrenheit) and HEADACHE (bad headache) had resolved.      No treatment of symptoms for Dose 1 was provided. Additional concomitant medication was Vitamin D 50000 twice a week.   This case was linked to US-MODERNATX, INC.-MOD-2021-081412 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081412:Case for dose 2
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis contact
Clinical narrative: Poison Oak; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DERMATITIS CONTACT (Poison Oak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DERMATITIS CONTACT (Poison Oak). The patient was treated with PREDNISONE for Adverse event, at a dose of 1 dosage form. At the time of the report, DERMATITIS CONTACT (Poison Oak) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment of poison oak was with prednisone on 19-Apr-2021. Patient was due for her second dose of COVID-19 vaccination on 20-Apr-2021 and wanted to know if she could still get COVID-19 vaccine even though she started steroid  (prednisone) last night.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Nausea; Felt tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and FATIGUE (Felt tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) and FATIGUE (Felt tired). At the time of the report, NAUSEA (Nausea) and FATIGUE (Felt tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The reporter stated that she had a lots of friends who experienced the events after receiving Moderna COVID-19 Vaccination.  No relevant concomitant medications were reported. No treatment information was reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pain in extremity, Pruritus, Swelling
Clinical narrative: red spot on palm; itching; raised area; fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red spot on palm), PRURITUS (itching), SWELLING (raised area), FATIGUE (fatigue) and PAIN IN EXTREMITY (sore arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No patient history was reported by reporter. .  The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ESTROGEN NOS;PROGESTERONE for Hormone replacement therapy.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FATIGUE (fatigue) and PAIN IN EXTREMITY (sore arm). On 08-Mar-2021, the patient experienced ERYTHEMA (red spot on palm), PRURITUS (itching) and SWELLING (raised area). At the time of the report, ERYTHEMA (red spot on palm), PRURITUS (itching), SWELLING (raised area), FATIGUE (fatigue) and PAIN IN EXTREMITY (sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-081415 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up received on 18-May-2021: outcome was updated to recovering On 19-May-2021: Follow up received on 19-MAY-2021 contained no new information.; Sender's Comments:  MOD-2021-081415:Dose 2 case
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Skin burning sensation
Clinical narrative: red spots on face, chest and arm; constant burning under the skin; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red spots on face, chest and arm) and SKIN BURNING SENSATION (constant burning under the skin) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced ERYTHEMA (red spots on face, chest and arm) and SKIN BURNING SENSATION (constant burning under the skin). At the time of the report, ERYTHEMA (red spots on face, chest and arm) and SKIN BURNING SENSATION (constant burning under the skin) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter.  Treatment information included steroids.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up received on 20-MAY-2021 included  Event outcome updated.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: red rash that extended from the shoulder to the elbow,rash is bright red; rash itches; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash that extended from the shoulder to the elbow,rash is bright red) and RASH PRURITIC (rash itches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced RASH ERYTHEMATOUS (red rash that extended from the shoulder to the elbow,rash is bright red) and RASH PRURITIC (rash itches). At the time of the report, RASH ERYTHEMATOUS (red rash that extended from the shoulder to the elbow,rash is bright red) and RASH PRURITIC (rash itches) had resolved. Not Provided          Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Follow up was received on 19 May 2021 included 2nd dose details and event outcome were updated.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Feeling of body temperature change, Pain, Pyrexia
Clinical narrative: body ache; felt very cold and very hot; Joint pain; fever 37.5C; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), FEELING OF BODY TEMPERATURE CHANGE (felt very cold and very hot), ARTHRALGIA (Joint pain), PYREXIA (fever 37.5C) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN (body ache), FEELING OF BODY TEMPERATURE CHANGE (felt very cold and very hot), ARTHRALGIA (Joint pain), PYREXIA (fever 37.5C) and CHILLS (chills). At the time of the report, PAIN (body ache), FEELING OF BODY TEMPERATURE CHANGE (felt very cold and very hot), ARTHRALGIA (Joint pain), PYREXIA (fever 37.5C) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Soreness in arm of injection; Redness in arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in arm of injection) and VACCINATION SITE ERYTHEMA (Redness in arm of injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm of injection) and VACCINATION SITE ERYTHEMA (Redness in arm of injection). On 18-Jan-2021, VACCINATION SITE PAIN (Soreness in arm of injection) and VACCINATION SITE ERYTHEMA (Redness in arm of injection) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  No treatment information was provided.      This case was linked to MOD-2021-081517 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 207L20A) for COVID-19 vaccination.     No reported medical history but consumer takes unspecified heart medications.  The patient's past medical history included No adverse event.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 09Apr2021, the consumer went to an urgent care facility because of  persisting diarrhea .  Laboratory test taken reported everything within normal limits. The consumer was treated with  Imodium and Pepto Bismol. On 14Apr2021, the consumer was seen by his primary physician. On 17Apr2021, the consumer started taking Metamucil. On 20Apr2021, the consumer reported that diarrhea was improving.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain) and PAIN IN EXTREMITY (pain left leg) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included Hip surgery. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain) and PAIN IN EXTREMITY (pain left leg). At the time of the report, BACK PAIN (back pain) and PAIN IN EXTREMITY (pain left leg) outcome was unknown. It was reported that all these symptoms were on the left side of patient's body. No concomitant medication was reported. Patient had back pain and was treated with cortisone. This case was linked to USMODERNATX INC. MOD 2021 081430 (E2B Linked Report).; Sender's Comments: USMODERNATX INC. MOD 2021 081430:First Dose.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Hand deformity, Pruritus, Vaccination site rash
Clinical narrative: rash at the injection site; itches; size of a "small woman's hand"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site), PRURITUS (itches) and HAND DEFORMITY (size of a "small woman's hand") in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site), PRURITUS (itches) and HAND DEFORMITY (size of a "small woman's hand"). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE RASH (rash at the injection site), PRURITUS (itches) and HAND DEFORMITY (size of a "small woman's hand") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications were reported.  Treatment medications include took 2 Tylenol .
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Cough, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: diarrhea; crumping muscle on back and neck; lost test and smell; severe headache; muscle and body aches "worse than during COVID or flu 3-4 times"; fever; fatigue; sore arm; node in injection site; cough; shortness of breath; muscles crumps; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath) and MUSCLE SPASMS (muscles crumps) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.  The patient's past medical history included COVID-19 (The patient was exposed to COVID on August2020.) in August 2020. Concomitant products included ALPRAZOLAM, ASPIRIN [ACETYLSALICYLIC ACID], CLONAZEPAM, CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), CETIRIZINE, CLONIDINE, CYCLOBENZAPRINE, FLUOXETINE, FLUTICASONE, GABAPENTIN, INSULIN LISPRO (HUMALOG), SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), LANSOPRAZOLE, LISINOPRIL, MELOXICAM and VITAMIN D NOS for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath), MUSCLE SPASMS (muscles crumps), AGEUSIA (lost test and smell), HEADACHE (severe headache), MYALGIA (muscle and body aches "worse than during COVID or flu 3-4 times"), PYREXIA (fever) and FATIGUE (fatigue). On 19-Apr-2021, the patient experienced MUSCLE SPASMS (crumping muscle on back and neck) and DIARRHOEA (diarrhea). The patient was treated with IBUPROFEN at a dose of 800 mg. On 19-Apr-2021, PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath), MUSCLE SPASMS (muscles crumps), AGEUSIA (lost test and smell), MYALGIA (muscle and body aches "worse than during COVID or flu 3-4 times"), PYREXIA (fever) and FATIGUE (fatigue) had resolved. At the time of the report, MUSCLE SPASMS (crumping muscle on back and neck), DIARRHOEA (diarrhea) and HEADACHE (severe headache) outcome was unknown.            Treatment also included using cold pack.   This case was linked to MOD-2021-081393 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: diarrhea; crumping muscle on back and neck; lost test and smell; severe headache; muscle and body aches "worse than during COVID or flu 3-4 times"; fever; fatigue; sore arm; node in injection site; cough; shortness of breath; muscles crumps; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath) and MUSCLE SPASMS (muscles crumps) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.  The patient's past medical history included COVID-19 (The patient was exposed to COVID on August2020.) in August 2020. Concomitant products included ALPRAZOLAM, ASPIRIN [ACETYLSALICYLIC ACID], CLONAZEPAM, CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), CETIRIZINE, CLONIDINE, CYCLOBENZAPRINE, FLUOXETINE, FLUTICASONE, GABAPENTIN, INSULIN LISPRO (HUMALOG), SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), LANSOPRAZOLE, LISINOPRIL, MELOXICAM and VITAMIN D NOS for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath), MUSCLE SPASMS (muscles crumps), AGEUSIA (lost test and smell), HEADACHE (severe headache), MYALGIA (muscle and body aches "worse than during COVID or flu 3-4 times"), PYREXIA (fever) and FATIGUE (fatigue). On 19-Apr-2021, the patient experienced MUSCLE SPASMS (crumping muscle on back and neck) and DIARRHOEA (diarrhea). The patient was treated with IBUPROFEN at a dose of 800 mg. On 19-Apr-2021, PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath), MUSCLE SPASMS (muscles crumps), AGEUSIA (lost test and smell), MYALGIA (muscle and body aches "worse than during COVID or flu 3-4 times"), PYREXIA (fever) and FATIGUE (fatigue) had resolved. At the time of the report, MUSCLE SPASMS (crumping muscle on back and neck), DIARRHOEA (diarrhea) and HEADACHE (severe headache) outcome was unknown.            Treatment also included using cold pack.   This case was linked to MOD-2021-081393 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: diarrhea; crumping muscle on back and neck; lost test and smell; severe headache; muscle and body aches "worse than during COVID or flu 3-4 times"; fever; fatigue; sore arm; node in injection site; cough; shortness of breath; muscles crumps; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath) and MUSCLE SPASMS (muscles crumps) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.  The patient's past medical history included COVID-19 (The patient was exposed to COVID on August2020.) in August 2020. Concomitant products included ALPRAZOLAM, ASPIRIN [ACETYLSALICYLIC ACID], CLONAZEPAM, CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), CETIRIZINE, CLONIDINE, CYCLOBENZAPRINE, FLUOXETINE, FLUTICASONE, GABAPENTIN, INSULIN LISPRO (HUMALOG), SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), LANSOPRAZOLE, LISINOPRIL, MELOXICAM and VITAMIN D NOS for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath), MUSCLE SPASMS (muscles crumps), AGEUSIA (lost test and smell), HEADACHE (severe headache), MYALGIA (muscle and body aches "worse than during COVID or flu 3-4 times"), PYREXIA (fever) and FATIGUE (fatigue). On 19-Apr-2021, the patient experienced MUSCLE SPASMS (crumping muscle on back and neck) and DIARRHOEA (diarrhea). The patient was treated with IBUPROFEN at a dose of 800 mg. On 19-Apr-2021, PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (node in injection site), COUGH (cough), DYSPNOEA (shortness of breath), MUSCLE SPASMS (muscles crumps), AGEUSIA (lost test and smell), MYALGIA (muscle and body aches "worse than during COVID or flu 3-4 times"), PYREXIA (fever) and FATIGUE (fatigue) had resolved. At the time of the report, MUSCLE SPASMS (crumping muscle on back and neck), DIARRHOEA (diarrhea) and HEADACHE (severe headache) outcome was unknown.            Treatment also included using cold pack.   This case was linked to MOD-2021-081393 (Patient Link).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Burning sensation, Chills, Confusional state, Diarrhoea
Clinical narrative: so cold; feet feel like they are on fire; loose bowel, gone several times a day; has lost 15 lbs; very weak; Fatigued/Tired; headache, on and off headache; chills; very confused; felt like he was in a fog; pain in the kidney area, still pain in kidney area; barely breath; sort of mumbling; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (very confused), FEELING ABNORMAL (felt like he was in a fog), RENAL PAIN (pain in the kidney area, still pain in kidney area), DYSPNOEA (barely breath) and SPEECH DISORDER (sort of mumbling) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical History.  Concomitant products included METFORMIN, ATORVASTATIN, DONEPEZIL HCL, ANDROGRAPHIS PANICULATA, ASCORBIC ACID, ECHINACEA PURPUREA, OLEA EUROPAEA, ZINC CHELATE (IMMUNE DEFENCE), QUERCETIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced CONFUSIONAL STATE (very confused). 20-Apr-2021, the patient experienced FEELING ABNORMAL (felt like he was in a fog), RENAL PAIN (pain in the kidney area, still pain in kidney area), DYSPNOEA (barely breath), SPEECH DISORDER (sort of mumbling), FATIGUE (Fatigued/Tired), HEADACHE (headache, on and off headache) and CHILLS (chills). On an unknown date, the patient experienced FEELING COLD (so cold), BURNING SENSATION (feet feel like they are on fire), DIARRHOEA (loose bowel, gone several times a day), WEIGHT DECREASED (has lost 15 lbs) and ASTHENIA (very weak). At the time of the report, CONFUSIONAL STATE (very confused), FEELING ABNORMAL (felt like he was in a fog), DYSPNOEA (barely breath), SPEECH DISORDER (sort of mumbling), FEELING COLD (so cold), BURNING SENSATION (feet feel like they are on fire), WEIGHT DECREASED (has lost 15 lbs), ASTHENIA (very weak), FATIGUE (Fatigued/Tired), HEADACHE (headache, on and off headache) and CHILLS (chills) outcome was unknown and RENAL PAIN (pain in the kidney area, still pain in kidney area) and DIARRHOEA (loose bowel, gone several times a day) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Newevents added. Event outcome updated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Feeling cold, Headache
Clinical narrative: so cold; feet feel like they are on fire; loose bowel, gone several times a day; has lost 15 lbs; very weak; Fatigued/Tired; headache, on and off headache; chills; very confused; felt like he was in a fog; pain in the kidney area, still pain in kidney area; barely breath; sort of mumbling; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (very confused), FEELING ABNORMAL (felt like he was in a fog), RENAL PAIN (pain in the kidney area, still pain in kidney area), DYSPNOEA (barely breath) and SPEECH DISORDER (sort of mumbling) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical History.  Concomitant products included METFORMIN, ATORVASTATIN, DONEPEZIL HCL, ANDROGRAPHIS PANICULATA, ASCORBIC ACID, ECHINACEA PURPUREA, OLEA EUROPAEA, ZINC CHELATE (IMMUNE DEFENCE), QUERCETIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced CONFUSIONAL STATE (very confused). 20-Apr-2021, the patient experienced FEELING ABNORMAL (felt like he was in a fog), RENAL PAIN (pain in the kidney area, still pain in kidney area), DYSPNOEA (barely breath), SPEECH DISORDER (sort of mumbling), FATIGUE (Fatigued/Tired), HEADACHE (headache, on and off headache) and CHILLS (chills). On an unknown date, the patient experienced FEELING COLD (so cold), BURNING SENSATION (feet feel like they are on fire), DIARRHOEA (loose bowel, gone several times a day), WEIGHT DECREASED (has lost 15 lbs) and ASTHENIA (very weak). At the time of the report, CONFUSIONAL STATE (very confused), FEELING ABNORMAL (felt like he was in a fog), DYSPNOEA (barely breath), SPEECH DISORDER (sort of mumbling), FEELING COLD (so cold), BURNING SENSATION (feet feel like they are on fire), WEIGHT DECREASED (has lost 15 lbs), ASTHENIA (very weak), FATIGUE (Fatigued/Tired), HEADACHE (headache, on and off headache) and CHILLS (chills) outcome was unknown and RENAL PAIN (pain in the kidney area, still pain in kidney area) and DIARRHOEA (loose bowel, gone several times a day) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Newevents added. Event outcome updated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Renal pain, Speech disorder, Weight decreased
Clinical narrative: so cold; feet feel like they are on fire; loose bowel, gone several times a day; has lost 15 lbs; very weak; Fatigued/Tired; headache, on and off headache; chills; very confused; felt like he was in a fog; pain in the kidney area, still pain in kidney area; barely breath; sort of mumbling; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (very confused), FEELING ABNORMAL (felt like he was in a fog), RENAL PAIN (pain in the kidney area, still pain in kidney area), DYSPNOEA (barely breath) and SPEECH DISORDER (sort of mumbling) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical History.  Concomitant products included METFORMIN, ATORVASTATIN, DONEPEZIL HCL, ANDROGRAPHIS PANICULATA, ASCORBIC ACID, ECHINACEA PURPUREA, OLEA EUROPAEA, ZINC CHELATE (IMMUNE DEFENCE), QUERCETIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced CONFUSIONAL STATE (very confused). 20-Apr-2021, the patient experienced FEELING ABNORMAL (felt like he was in a fog), RENAL PAIN (pain in the kidney area, still pain in kidney area), DYSPNOEA (barely breath), SPEECH DISORDER (sort of mumbling), FATIGUE (Fatigued/Tired), HEADACHE (headache, on and off headache) and CHILLS (chills). On an unknown date, the patient experienced FEELING COLD (so cold), BURNING SENSATION (feet feel like they are on fire), DIARRHOEA (loose bowel, gone several times a day), WEIGHT DECREASED (has lost 15 lbs) and ASTHENIA (very weak). At the time of the report, CONFUSIONAL STATE (very confused), FEELING ABNORMAL (felt like he was in a fog), DYSPNOEA (barely breath), SPEECH DISORDER (sort of mumbling), FEELING COLD (so cold), BURNING SENSATION (feet feel like they are on fire), WEIGHT DECREASED (has lost 15 lbs), ASTHENIA (very weak), FATIGUE (Fatigued/Tired), HEADACHE (headache, on and off headache) and CHILLS (chills) outcome was unknown and RENAL PAIN (pain in the kidney area, still pain in kidney area) and DIARRHOEA (loose bowel, gone several times a day) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Newevents added. Event outcome updated.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Neck pain, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: achy neck; Red oval circle at injection site; Itchy circle at the injection site; swollen lymph nodes in the left side; soreness in her left armpit; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (soreness in her left armpit), NECK PAIN (achy neck), LYMPHADENOPATHY (swollen lymph nodes in the left side), VACCINATION SITE ERYTHEMA (Red oval circle at injection site) and VACCINATION SITE PRURITUS (Itchy circle at the injection site) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced AXILLARY PAIN (soreness in her left armpit) and LYMPHADENOPATHY (swollen lymph nodes in the left side). On 19-Apr-2021, the patient experienced NECK PAIN (achy neck), VACCINATION SITE ERYTHEMA (Red oval circle at injection site) and VACCINATION SITE PRURITUS (Itchy circle at the injection site). At the time of the report, AXILLARY PAIN (soreness in her left armpit), NECK PAIN (achy neck), LYMPHADENOPATHY (swollen lymph nodes in the left side), VACCINATION SITE ERYTHEMA (Red oval circle at injection site) and VACCINATION SITE PRURITUS (Itchy circle at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided Treatment information was not provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Induration, Injection site swelling, Memory impairment
Clinical narrative: brain fog; forgetting common things; fatigue; upper arm got hard; itchy; swollen; rash; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (upper arm got hard), PRURITUS (itchy), FEELING ABNORMAL (brain fog), MEMORY IMPAIRMENT (forgetting common things) and INJECTION SITE SWELLING (swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced INDURATION (upper arm got hard), PRURITUS (itchy), INJECTION SITE SWELLING (swollen) and RASH (rash). On an unknown date, the patient experienced FEELING ABNORMAL (brain fog), MEMORY IMPAIRMENT (forgetting common things) and FATIGUE (fatigue). On 17-Apr-2021, FEELING ABNORMAL (brain fog), MEMORY IMPAIRMENT (forgetting common things) and FATIGUE (fatigue) had resolved. At the time of the report, INDURATION (upper arm got hard) and INJECTION SITE SWELLING (swollen) outcome was unknown and PRURITUS (itchy) and RASH (rash) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: brain fog; forgetting common things; fatigue; upper arm got hard; itchy; swollen; rash; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (upper arm got hard), PRURITUS (itchy), FEELING ABNORMAL (brain fog), MEMORY IMPAIRMENT (forgetting common things) and INJECTION SITE SWELLING (swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced INDURATION (upper arm got hard), PRURITUS (itchy), INJECTION SITE SWELLING (swollen) and RASH (rash). On an unknown date, the patient experienced FEELING ABNORMAL (brain fog), MEMORY IMPAIRMENT (forgetting common things) and FATIGUE (fatigue). On 17-Apr-2021, FEELING ABNORMAL (brain fog), MEMORY IMPAIRMENT (forgetting common things) and FATIGUE (fatigue) had resolved. At the time of the report, INDURATION (upper arm got hard) and INJECTION SITE SWELLING (swollen) outcome was unknown and PRURITUS (itchy) and RASH (rash) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information was provided.